RXC005, a potent and selective, reversible BTK inhibitor targeting both wild-type and mutant C481S BTK with potent efficacy in ABC-DLBCL xenograft mouse modelsNicolas Guisot,Stuart Best,Andrew Thomason,Victoria Wright,Jennifer Woyach,Rose Mantel,Fabienne McClanahan,Valentina Abet,Diana Castagna, Peggy Cousin,Juliette Emmerich,Kelvin Ho,James Kelly,Kristina Lyons,Melanie Muller,Julienne Refuerzo,Louise Sargent,Fatima Talab,Matilda Bingham,Caroline Phillips,Richard ArmerLEUKEMIA & LYMPHOMA（2017）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
